• 제목/요약/키워드: 체외 수정

검색결과 605건 처리시간 0.023초

난소 낭종이 체외수정시술을 위한 과배란유도 주기에 미치는 영향에 관한 연구 (The Effects of Ovarian Cysts on the Controlled Ovarian Hyperstimulation Cycles for In Vitro Fertilization and Embryo Transfer Program)

  • 황태영;김석현;신창재;김정구;문신용;이진용;장윤석
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제16권2호
    • /
    • pp.205-210
    • /
    • 1989
  • To investigate the effects of ovarian cysts on the controlled ovarian hyper-stimulation cycles, 16 patients with 16 paired cycles for IVF-ET were analyzed. These patients had taken both type of cycles, i.e., with cyst(cyst group) and without cyst(control group). Mean diameter of ovarian cysts in cyst group was 18.2mm. There were no significant differences in hormone levels in early follicular phase between two groups. No significant differences were found in total dosage of hMG(IU) administered during the ovarian stimulation $843.8{\pm}123.0$ vs $891.0{\pm}129.8$, serum estradiol level (pg/ml) on the day of hCG administration($1542.8{\pm}1100.6$ vs $1567.5{\pm}1193.0$), the number of aspirated follicles $10.0{\pm}3.4$ vs $11.2{\pm}4.3$ and oocytes $5.3{\pm}3.3$ vs $6.2{\pm}3.1$, the fertilization rate(51.2 % vs 57.2 %) and the cleavage rate(40.5 % vs 52.0 %). Serum estradiol terminal patterns during COH in one group tended to be repeated in the other group. In conclusion, this study suggests that small ovarian cysts do not adversely impact on the controlled ovarian hyperstimulation parameters in IVF - ET program and the presence of small ovarian cyst without concomitant high basal serum estradiol level is not an indication of the cancellation of the controlled ovarian hyperstimulation for IVF-ET.

  • PDF

생쥐 초기 배아의 'In Vitro 2-Cell Block'현상에 관한 연구

  • 김해권;공희숙;조완규
    • 한국동물학회지
    • /
    • 제29권1호
    • /
    • pp.13-22
    • /
    • 1986
  • 특정 계통의 생쥐 초기 배아의 체외 배양때에 나타나는 "In Vitro 2-Cell Block" 현상을 규명할 것을 목적으로 하고 본 실험이 행해졌다. 먼저 이 현상이 발생하는 ICR 계통의 생쥐의 수정란 또는 2세포기의 배아를 일정시간 대 (배란을 유도하기 위한 hCG주사시간을 기준)를 두고 수란관으로부터 회수한 뒤 이를 3-4일간 배양하면서 배낭으로까지의 발생능력을 알아보았다. 그 결과 hCG주사 후 약 30시간이 지난 뒤 수란관에서 회수한 수정란이나 2세포기의 배아의 일부가 배낭으로까지 발생하였으며 만일 48시간이 지나면 수란관 내에서 회수된 배아는 대부분이 2세포기 배아이며 이것들은 거의 배낭으로 발생하였다. HCG 주사 후 27시간이 지난 수란관으로부터 회수한 수정란을 2시간에서 24시간을 배양한 뒤 이들을 다시 수란관에 이식하여 기관배양법에 의해 72시간 배양하고 다시 수란관 밖에서 배아를 24시간 배양해 본 결과, 배아들이 수란관 밖의 환경에서 배양된 시간이 길수록 이것들을 다시 수란관내에 되돌려 준다 하더라도 배낭으로까지 발생할 능력을 크게 상실하였다. 이같은 실험 결과로 보아 생쥐의 수정란이 "2-Cell Block" 현상을 극복하기 위해서는 수정후 일정시간 이상을 수란관이라는 환경내에 머물러 있어야 한다는 것을 알게 되었다. 즉, 배아는 수란관에 오래 머물러 있을수록, 그리고 수란관으로부터 축출되더라도 다시 수란관으로 돌려보내질 때까지 밖에 머물러 있는 시간이 짧을수록, 수정란 혹은 2세포기 배아의 배낭으로의 발생능력은 정상에 가깝게 유지되는 것이다. "2-Cell Block"에 걸려있는 2세포기의 배아는 배양 후 24시간까지에는 광학현미경적인 관찰 결과 정상적인 형태를 보여주고 있었으나 48시간이 되면 핵의 이상응축이 나타나며 72시간이 경과하면 세포질 내에 비정상적인 공포들이 나타나고 있었다.

  • PDF

미세수술적 난관복원술 후 임신에 실패한 환자에서의 체외수정시술 결과 (Outcomes of IVF-ET in Infertile Patients with Failed Microsurgical Reversal of Tubal Sterilization)

  • 김석현;홍준석;구승엽;서창석;최영민;김정구;문신용;이진용
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제28권4호
    • /
    • pp.307-315
    • /
    • 2001
  • Objective: To evaluate the clinical outcomes and influencing factors of in vitro fertilization and embryo transfer (IVF-ET) in patients with failed pregnancy after microsurgical reversal of tubal sterilization. Materials and Methods : From January, 1997 to December, 2000, IVF-ET was performed in two groups; the study TR (tubal reanastomosis) group consisted of 147 cycles in 66 patients with failed microsurgical reversal of tubal sterilization, and the control group of 115 cycles in 67 patients with bilateral tubal occlusion (BTO). The two groups were evaluated and compared for clinical characteristics, clinical pregnancy rates, and factors influencing the outcomes of IVF-ET. Results: Compared with the control BTO group, age and the previous parity were significantly higher ($36.3{\pm}2.7$ vs. $33.6{\pm}2.0$ years, p<0.05; $1.6{\pm}0.7$ vs. $0.2{\pm}0.4$, p<0.05), and the clinical pregnancy rate per cycle was significantly lower (23.8% (35/147) vs. 29.3% (34/115), p<0.05) in the TR group. Difference in the clinical pregnancy rates was age-related, since there was no significant difference between the two groups, except for the previous parity ($1.6{\pm}0.7$ vs. $0.1{\pm}0.3$, p<0.05), when the patients aged 37 years or older were excluded. No difference was found in terms of the following: the proportion of controlled ovarian hyperstimulation (COH) cycles with GnRH agonist ultrashort protocol, the duration of COH, the dosage of gonadotropins used, and the numbers of oocytes retrieved and of embryos transferred, irrespective of age correction. Conclusions: The outcomes of IVF-ET following the failed microsurgical reversal of tubal sterilization depend upon patient age. The previous fertility of patients does not seem to be a factor of better IVF-ET prognosis.

  • PDF

기초 혈중 Follicle Stimulating Hormone 농도가 높은 체외수정시술 환자의 과배란유도시 Gonadotropin-Releasing Hormone Agonist의 단기투여법과 장기투여법의 비교 (Comparison of Superovulation Outcomes between Short and Long Protocols Using Gonadotropin-Releasing Hormone Agonist in Patients with High Basal Serum Follicle Stimulating Hormone Levels)

  • 김석현;송은섭;송용상;이경희;김정구;문신용;이진용;장윤석
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제18권2호
    • /
    • pp.201-208
    • /
    • 1991
  • Recently the application of gonadotropin-releasing hormone (GnRH) agonist to superovulation in previous poor responders has resulted in the improved outcomes after in vitro fertilization (IVF) outcome. However, poor responders with poor estradiol $(E_2)$ rise or single dominant follicle are a particularly challenging group. Recent reports have also shown that patients with higher basal serum follicle stimulating hormone (FSH) level, result in poorer ovarian response and lower pregnancy rate. Analysis of the differences of superovulation outcomes according to the different protocols of GnRH agonist, long (L, n = 18) and short (S, n = 16) protocols, in patients with high basal FSH levels (>20mIU/ml) were undertaken at Seoul National University Hospital from June to October 1990. The administration of GnRH agonist was begun on day 21 of the cycle in long protocol, and on day 2 in short protocol. Ages of patients and husbands, basal FSH and luteinizing hormone (LH) levels and FSH/LH ratio did not differ significantly. Types and causes of infertility were evenly distributed. Whereas the duration of stimulation and the amounts of gonadotropins administered were significantly reduced in short protocol, the numbers of oocytes retrieved and cleaved, the cleavage rate and the number of embryos transferred were higher in long protocol without statistical signifieance. The pregnancy rate per ET was 16.7% (2/12) in short protocol, and 17.6% (3/17) in long protocol. These data suggest that both protocols result in the similar superovulation outcomes in patients with higher basal serum FSH levels.

  • PDF

의암호 말조개, Unio douglasiae (Unionidae) 의 번식생태 (Reproductive Ecology of the Freshwater Bivalve, Unio douglasiae (Unionidae) in Lake Uiam)

  • 송미영;임지례;이완옥;김성태;김대희
    • 한국패류학회지
    • /
    • 제31권3호
    • /
    • pp.171-178
    • /
    • 2015
  • 의암호에 서식하고 있는 말조개의 성장과 산란생태를 파악하기 위하여, 2014년 3월부터 2015년 2월까지 상대성장식, 생식소 발달단계에 따른 생식주기와 군성숙도의 월별변화를 조사하였다. 각장에 대한 각고, 각폭, 전중, 육중간의 상대성장식에서 상관계수 ($R^2$) 는 0.814-0.944로 높은 상관관계를 나타내었다. 말조개의 생식소는 소화맹낭의 주변부와 족부로 연결되는 망상결체조직에 분포하며 자웅이체로, 성숙한 난과 정자는 수관을 통해 아가미 반새에서 수정되어 수정란을 아가미의 보육낭에서 부화시켜 체외로 방출하는 난태생종이었다. 서식 지역의 월별 평균수온은 $3.9-25.9^{\circ}C$ 범위였다. 월별 비만도는 0.16-0.22 범위로 하계인 8월-9월에 낮은 값을 보이다가 10월부터 증가하여 11월과 1월에 0.22로 정점을 보였다. 월별 육중량비는 21.3-31.4%로 비만도의 월별 변화와 같은 경향을 나타내었다. 생식소지수는 0.00-4.00 범위를 나타내었고, 4월-7월까지 정점을 보인 후 8월부터 급격히 감소하였다. 생식년주기는 분열증식기 (11-1월), 성장기 (2-3월), 성숙기 (2-5월), 산란기 (4-9월), 회복기 (8-12월)로 구분되어 하계산란종이었다. 의암호산 말조개의 산란기는 4-9월 (주산란기 4-7월) 이였으며, 군성숙 각장은 29.4 mm였다.

Swim-up, Percoll, Sil-Select를 이용한 정자처리법에 의한 정자회수율, 운동성 및 체외수정율의 비교분석 (Comparison of Sperm Motility, Recovery Rate, and Fertilization Rate using Three Different Sperm Preparation Methods: Swim-up, Percoll, Sit-Select)

  • 하정희;엄기붕;정형민;정미경;김현규;고정재;윤태기;차광열
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제26권2호
    • /
    • pp.257-263
    • /
    • 1999
  • It is well known that discard of seminal plasma from the semen and separation of motile sperm should be preceded before insemination for IUI or IVF. Till now, more than ten kinds of semen treatment methods have been developed. Of those, swim-up and Percoll methods have been used widely in ART laboratories as a routine semen treatment methods because of its advantages. However, there are reports that Percoll can make a genetic trouble because of its chemical structure and therefore the necessity has been arisen to substitute Percoll for other equivalent materials. This study was performed to evaluate the effects of three different sperm preparation methods (swim-up, Percoll and Sil-Select) on sperm motility, sperm recovery rate and fertilization rate. Also, the feasibility of using Sil-Select instead of Percoll in ART was evaluated. Each semen samples were divided into three fractions and motile sperm were recovered by swim-up, Percoll and Sil-Select gradient centrifugation methods. Normal and sub-normal criteria of fifteen semen samples and seventeen IVF cycles were included in these study. As results, no significant difference was found in sperm recovery rate in normal semen treated by a Swim-up, Percoll and Sil-Select method ($13.2{\times}10^6,\;17.5{\times}10^6\;and\;17.7{\times}10^6$ respectively). The initial sperm motility was 61.9% and this increased to 87.1%, 92.6% and 89.5% through Swim-up, Percoll and Sil-Select treatment, respectively. Higher motility was observed in Percoll and Sil-Select treated groups (81.5%, 79.2%, respectively) than swim-up group (66.8%) after incubation for 24hrs. In sub-normal group, sperm recovery rates were higher in Sil-Select group $(2.9{\times}10^6)$ than Percoll gradients group $(1.8{\times}10^6)$. In IVF cycles, the outcomes of fertilization using sperm treated by swim-up and Sil-Select group were similar (82.2%, 79.7% respectively). In conclusion, our results indicate that Sil-Select can be used as a substitute material for sperm preparation instead of Percoll.

  • PDF

일반적인 체외수정 방법과 세포질내 정자주입술로 얻어진 배아의 동결-융해 후 이식의 결과 (Results of Transfer of Cryopreserved Supernumerary Embryos Obtained after Conventional in vitro Fertilization and Intracytoplasmic Sperm Injection (ICSI))

  • 김정욱;한미현;변혜경;전진현;손일표;궁미경;백은찬;강인수;이호준
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제24권1호
    • /
    • pp.111-118
    • /
    • 1997
  • Intracytoplasmic sperm injection (ICSI) recently has been utilized widely as the most successful technique to overcome the unfertilization problem in cases of severe male infertility in couples who could not be treated by conventional IVF. Recently, indications of ICSI have been extended further and more fertilized oocytes become available. Thus, it is necessary to examine the efficiency of freezing the surplus embryos obtained from ICSI. We compared the survival rate and the future outcome of cryopreserved embryos obtained either after conventional IVF or ICSI during the same period. After ICSI or IVF, five best-quality embryos from each patient were transferred in the stimulation cycle and the surplus pronuclear (PN) stage oocytes or multicellular embryos were cryopreserved by slow freezing protocol with 1,2-propanediol (PROH) as a cryoprotectant. A total of 792 embryos from ICSI trial were thawed and 65.2% (516/792) survived. The survival rates of PN stage oocyte, multicellular embryo and PN + multicellular embryo were 63.5%, 68.2%, 64.0%, respectively. After 111 transfers, 34 pregnancies were achieved, corresponding to a clinical pregnancy rate of 30.6% per transfers. We thawed 1033 embryos from IVF trials and 57.5% (594/1033) survived. In IVF cycle, the survival rates of PN stage oocyte, multicellular embryo and PN + multicellular embryo were 58.2%, 65.2%, 40.2%, respectively. Thirty eight clinical pregnancies were established after 134 transfers, corresponding to a pregnancy rate of 28.4% per transfer. The cleavage rate of thawed PN stage oocytes from ICSI trial (61.3%) was significantly higher than those from conventional IVF (53.4%). The developmental rates of good embryo (${\geqq}$ grade II) in thawed PN stage oocytes obtained from conventional IVF and ICSI were 63% and 65%, respectively. We concluded that PN stage oocytes, multicellular embryos resulting from ICSI procedure can be successfully frozen/thawed with reasonable clinical pregnancy rates comparable to those of IVF.

  • PDF

체외수정시술을 위한 과배란유도시 Highly Purified Follicle Stimulating Hormone (HP-FSH) 피하주사와 Follicle Stimulating Hormone 근육주사의 비교연구 (Subcutaneous Administration of Highly Purified-FSH(HP-FSH) versus Intramuscular Administration of FSH in Superovulation for IVF-ET)

  • 배상욱;김진영;원종건;정창진;장경환;이병석;박기현;조동제;송찬호
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제24권1호
    • /
    • pp.135-141
    • /
    • 1997
  • The early studies demonstrated that the relative amount of FSH was important for stimulating normal ovarian activity and demonstrated the existence of a threshold level for FSH, above which follicular growth was activated. It was found that only a modest increase in circulating FSH level above the threshold (between 10 and 30%) was required to stimulate folliculogenesis. In addition, FSH is primary responsible for initiating estradiol production through the activation of the aromatase enzyme system in granulosa cells, follicular secretion and growth. LH on the other hand, plays a supportive role in ovarian steroidogenesis, stimulating the ovarian thecal cells to produce androgen, the precursor for estradiol synthesis. But there is now an increasing number of reports in the literature demonstrating an adverse effect of LH on fertility and miscarriage in infertile and fertile women. So HP-FSH is the drug of a highly purified FSH preparation which has a higher specific activity and far fewer impurities than FSH. This study was performed to evaluate the efficacy and safety of HP-FSH administered (SC; subcutaneous) versus FSH(IM; intramuscular) for ovulation induction. 20 candidates patients for ovulation induction were participated. All patients underwent pituitary desensitizing with a long gonadotropin-releasing hormone (GnRH) agonist protocol and ovulation induction was started with HP-FSH SC (10 patients; group I) or FSH IM (10 patients; group II). After ovulation, outcome of ovulation induction and local reaction of injection site were compared. There were no difference of outcome of ovulation in two groups except pregnancy rate/embryo transfer. Group I had a higher pregnancy rate/ embryo transfer than Group II (44.4% Vs 28.6%). Pain, redness, tenderness, bruising and itching when the injection received on the first 5 days of treated (50 SC and 50 IM injections) were assessed. There were no significant difference (P>0.05) in the incidence of tenderness, bruising and itching between the IM and SC injection. But IM injection (FSH) had a tendency of higher above incidence. The number of reports of pain, redness were significantly increased in IM injection group (P<0.05). These results indicate that SC administration of HP-FSH has been shown to be as effect for superovulation as traditional gonadotropins, with an improved safety profile due to the removal of extaneous proteins.

  • PDF

난소의 자궁내막종에 대한 다양한 치료적 적용에 따른 체외수정 및 배아이식술 결과의 비교 연구 (Comparison of IVF-ET Outcome after Various Therapeutic Approaches for Ovarian Endometriomas)

  • 이방현;권혁찬;이재현;김보현;이상희;박민혜;이병관;임정애
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제31권2호
    • /
    • pp.95-103
    • /
    • 2004
  • Objective: To compare COH characteristics and IVF outcomes among IVF-ET patients who were treated with various therapeutic modalities for ovarian endometriomas and to propose effective pre-cyclic therapeutic modalities to improve IVF-ET outcomes in the patients with ovarian endometriomas. Methods: All cases that had undergone IVF-ET after laparoscopy between January 1997 to August 2003 were reviewed. Forty-eight patients with tubal factor were assigned to Group I. Twenty seven, 22 and 38 patients diagnosed as severe pelvic adhesion with ovarian endometriomas by laparoscopy received only medical therapy (Group II), cyst aspiration (Group III), and sclerotherapy (Group IV), respectively. Laparoscopic cystectomy was performed in 20 patients (Group V). Resistance index was measured on day administering hCG. Results: As compared with Group I, in Group II resistance index increased (p<0.05) but number of oocytes, good-quality oocyte ratio (mature and intermediate oocytes/total retrieval oocytes), fertilization rate, and embryo development rate decreased (p<0.05). In Group III fertilization rate and embryo development rate decreased (p<0.05). There was no difference between Group IV and Group I in all parameters except basal FSH which increased (p<0.05). In Group V basal FSH, and resistance increased (p<0.05) and number of oocytes and good-quality oocytes ratio decreased (p<0.05). Conclusion: Sclerotherapy is an effective therapeutic option which can be done prior to IVF-ET cycles in the patients with ovarian endometriomas. Further studies on a large scale are necessary to confirm these data.

남성 불임의 진단 및 체외수정의 예후인자로서 정자 형태의 정밀 분석과 정자 첨체반응 및 햄스터 난자 침투 분석의 비교 연구 (Comparison of Sperm Morphology Evaluation Using Strict Criteria, Acrosome Reaction Following Ionophore Challenge and Zona-free Hamster Ova Sperm Penetration Assay as Prognostic Factors in Diagnosis of Male Infertility and In Vitro Fertilization)

  • 문신용;류범용;방명걸;오선경;이재훈;서창석;김석현;최영민;김정구;이진용
    • Clinical and Experimental Reproductive Medicine
    • /
    • 제29권1호
    • /
    • pp.57-66
    • /
    • 2002
  • Objective : This study was designed to investigate the interrelationship and clinical usefulness of sperm morphology by strict criteria (SM), acrosome reaction following ionophore challenge test (ARIC) and sperm penetration assay (SPA) using zona-free hamster ova as prognostic factors in in vitro fertilization. Materials and Methods: Semen samples were provided by 83 patients undergoing IVF. We first evaluated the differences between normal fertilization group and poor fertilization group on three andrologic tests. Secondly, we analyzed the relationship between the three andrologic tests and in vitro fertilization on IVF settings. Finally, we evaluated the effectiveness of the three andrologic tests as the prognostic indicators for fertilizing ability. Results: The fertilization rate of all men in the poor fertilization group was less than 30%; but there was no evidence that this poor fertilization was due to oocyte defects. The results of three andrologic tests were significatly higher in normal fertilization group. Fertilization rate (%) in vitro was highly correlated (p<0.001) with % normal sperm by SM, ARIC value (%), and SPA result. By using Receiver-Operator-Characteristic curve (ROC), we evaluated the effectiveness of these three tests. The sensitivity and specificity of SM, ARIC test and SPA in predicting fertilization potential in IVF setting were 76% and 75%, 84% and 90%, and 76% and 95%, respectively. Conclusion: Our data suggest that the three andrologic tests can be reliable tools as prognostic factors of sperm fertilizing ability. Among these test, ARIC test and SPA gave more accurate information on fertilizing capacity. ARIC test was shown to have a predictive value for fertilizing ability comparable to that of SPA that appears to be a simple and cost-effective addition to current andrology laboratory. Combined application of these three tests may give more information on predicting sperm fertilizing capacity.